Physician profile
Omar Syed
NPI 1902165046
$9,724.47
in general payments reported to CMS, 2019-2025
35 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $597 · 2021: $2,777 · 2022: $1,772 · 2023: $914 · 2024: $1,502 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,980.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,939.15 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,795.08 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $1,255.73 | 2019-2024 | Senza |
| Boston Scientific Corporation | $991.05 | 2019-2025 | Avista Mri |
| Si-Bone, INC. | $439.00 | 2022-2024 | |
| Globus Medical, INC. | $416.96 | 2025 | Senza, Affirm, Omnia |
| Nuvasive, INC. | $306.72 | 2022-2023 | Xlif |
| Nalu Medical, INC. | $237.89 | 2021-2024 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $234.20 | 2019-2020 | |
| Providence Medical Technology, INC. | $146.27 | 2025 | |
| Grt US Holding, INC. | $138.90 | 2020-2021 | |
| Saluda Medical Americas, INC. | $135.78 | 2025 | Evoke |
| Sirtex Medical INC | $98.94 | 2025 | Sir-Spheres Microspheres |
| Collegium Pharmaceutical, INC. | $85.21 | 2021-2025 | Belbuca, Xtampza |
| Teva Pharmaceuticals USA, INC. | $72.53 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $42.00 | 2022 | |
| Electronic Waveform Lab, INC. | $41.41 | 2024-2025 | |
| Biotronik Nro, INC. | $34.51 | 2024 | Prospera |
| Allergan, INC. | $24.17 | 2019-2020 | |
| Fidia Pharma USA INC. | $23.56 | 2024 | Hymovis |
| Sentynl Therapeutics, INC. | $23.51 | 2019 | |
| Amgen INC. | $23.18 | 2020 | |
| Stryker Corporation | $22.94 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.13 | 2025 | |
| Radius Health, INC. | $21.80 | 2019 | |
| Lilly USA, LLC | $21.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.00 | 2019 | |
| Impactortho, INC. | $19.92 | 2025 | |
| Painteq LLC | $16.99 | 2024 | Painteq |
| Abbvie INC. | $16.04 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.02 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.54 | 2019 | |
| Forte Bio-Pharma LLC | $11.81 | 2019 | |
| Pfizer INC. | $11.08 | 2019 | |
| Spr Therapeutics, INC | $5.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.